319 related articles for article (PubMed ID: 23775099)
21. Polidocanol for endovenous microfoam sclerosant therapy.
Eckmann DM
Expert Opin Investig Drugs; 2009 Dec; 18(12):1919-27. PubMed ID: 19912070
[TBL] [Abstract][Full Text] [Related]
22. Sclerotherapy for leg telangiectasia--a blinded comparative trial of polidocanol and hypertonic saline.
McCoy S; Evans A; Spurrier N
Dermatol Surg; 1999 May; 25(5):381-5; discussion 385-6. PubMed ID: 10469077
[TBL] [Abstract][Full Text] [Related]
23. Treatment of varicose tributaries with sclerotherapy with polidocanol 0.5 % foam.
Reich-Schupke S; Weyer K; Altmeyer P; Stücker M
Vasa; 2010 May; 39(2):169-74. PubMed ID: 20464673
[TBL] [Abstract][Full Text] [Related]
24. The use of sclerotherapy with polidocanol foam in the treatment of second-degree haemorrhoidal disease - a video vignette.
Lobascio P; Minafra M; Laforgia R; Giove C; Trompetto M; Gallo G
Colorectal Dis; 2019 Feb; 21(2):244-245. PubMed ID: 30485654
[No Abstract] [Full Text] [Related]
25. Sclerotherapy for Reticular Veins in the Lower Limbs: A Triple-Blind Randomized Clinical Trial.
Bertanha M; Jaldin RG; Moura R; Pimenta REF; Mariúba JVO; Lúcio Filho CEP; Alcantara GP; Padovani CR; Yoshida WB; Sobreira ML
JAMA Dermatol; 2017 Dec; 153(12):1249-1255. PubMed ID: 28973414
[TBL] [Abstract][Full Text] [Related]
26. Sclerotherapy with 3% polidocanol foam: revolutionizing outpatient treatment in patients with haemorrhoidal disease.
Gallo G; Ronconi M; Trompetto M
Updates Surg; 2021 Oct; 73(5):2029-2030. PubMed ID: 33660166
[No Abstract] [Full Text] [Related]
27. Treatment of male varicoceles by transcatheter polidocanol foam sclerotherapy: evaluation of clinical success, complications, and patients' satisfaction with regard to alternative techniques.
Ali A; Wirth S; Treitl KM; Treitl M
Eur Radiol; 2015 Oct; 25(10):2889-97. PubMed ID: 25796582
[TBL] [Abstract][Full Text] [Related]
28. Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins.
Rao J; Wildemore JK; Goldman MP
Dermatol Surg; 2005 Jun; 31(6):631-5; discussion 635. PubMed ID: 15996411
[TBL] [Abstract][Full Text] [Related]
29. Comparison of polidocanol foam versus bleomycin polidocanol foam for treatment of venous malformations.
He B; Yang B; Nie QQ; Zhang JB; Chen J; Liu P; Fan XQ; Ye ZD
J Vasc Surg Venous Lymphat Disord; 2023 Jan; 11(1):143-148. PubMed ID: 35940448
[TBL] [Abstract][Full Text] [Related]
30. Interim results of bleomycin-polidocanol foam sclerotherapy as a highly efficient technique for venous malformations.
Yang X; Chen H; Gu H; Jin Y; Hu L; Hua C; Wang Y; Sun Y; Yu W; Lin X
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1066-1073. PubMed ID: 32284311
[TBL] [Abstract][Full Text] [Related]
31. Polidocanol sclerotherapy for painful venous malformations: evaluation of safety and efficacy in pain relief.
Mimura H; Fujiwara H; Hiraki T; Gobara H; Mukai T; Hyodo T; Iguchi T; Yasui K; Kimata Y; Kanazawa S
Eur Radiol; 2009 Oct; 19(10):2474-80. PubMed ID: 19440712
[TBL] [Abstract][Full Text] [Related]
32. Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO).
Choi SY; Won JY; Kim KA; Lee DY; Lee KH
Eur Radiol; 2011 Jan; 21(1):122-9. PubMed ID: 20737152
[TBL] [Abstract][Full Text] [Related]
33. Successful Sclerotherapy for Cervicofacial Macrocystic Lymphatic Malformations Using Polidocanol and Pingyangmycin Combined Foam Sclerosants.
Wang Q; Zhou Q; Zhao Z; Liu C; Zheng J
Lymphat Res Biol; 2022 Oct; 20(5):507-513. PubMed ID: 35041550
[No Abstract] [Full Text] [Related]
34. Sclerotherapy and foam sclerotherapy for varicose veins.
Coleridge Smith P
Phlebology; 2009 Dec; 24(6):260-9. PubMed ID: 19952382
[TBL] [Abstract][Full Text] [Related]
35. Single-blind, randomized study comparing chromated glycerin, polidocanol solution, and polidocanol foam for treatment of telangiectatic leg veins.
Kern P; Ramelet AA; Wutschert R; Bounameaux H; Hayoz D
Dermatol Surg; 2004 Mar; 30(3):367-72; discussion 372. PubMed ID: 15008862
[TBL] [Abstract][Full Text] [Related]
36. Sclerotherapy for congenital vascular malformations with mixing foam of polidocanol and liquid of bleomycin.
Yang WH; Xiang XJ; Li HL
Phlebology; 2023 Aug; 38(7):451-457. PubMed ID: 37318342
[TBL] [Abstract][Full Text] [Related]
37. Foam sclerotherapy for spouting haemorrhage in patients with varicose veins.
Hamahata A; Yamaki T; Osada A; Fujisawa D; Sakurai H
Eur J Vasc Endovasc Surg; 2011 Jun; 41(6):856-8. PubMed ID: 21420881
[TBL] [Abstract][Full Text] [Related]
38. Comparison of bleomycin polidocanol foam vs electrochemotherapy combined with polidocanol foam for treatment of venous malformations.
Liu JW; Ni B; Gao XX; He B; Nie QQ; Fan XQ; Ye ZD; Wen JY; Liu P
J Vasc Surg Venous Lymphat Disord; 2024 Mar; 12(2):101697. PubMed ID: 37890588
[TBL] [Abstract][Full Text] [Related]
39. Short-Term Results of Sclerotherapy with 3% Polidocanol Foam for Symptomatic Second- and Third-Degree Hemorrhoidal Disease.
Lobascio P; Laforgia R; Novelli E; Perrone F; Di Salvo M; Pezzolla A; Trompetto M; Gallo G
J Invest Surg; 2021 Oct; 34(10):1059-1065. PubMed ID: 32290709
[TBL] [Abstract][Full Text] [Related]
40. Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2 year-follow-up. "The 3/1 Study".
Hamel-Desnos C; Ouvry P; Benigni JP; Boitelle G; Schadeck M; Desnos P; Allaert FA
Eur J Vasc Endovasc Surg; 2007 Dec; 34(6):723-9; discussion 730. PubMed ID: 17884623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
